Mușat & Asociații and Hogan Lovells assisted Romgaz in the first bond issue in the natural gas sector, a historic project on the capital market, which generated huge interest from international investors

Press News 2024

Press release Bucharest, 14 October 2024 EUR 1.5 billion – total amount of the international bond issuance program. EUR 500 million – the value of bonds issued in the first tranche. EUR 6 billion – demand registered from investors for the first tranche. Mușat & Asociații, in collaboration with the international law firm Hogan Lovells,…

Print Friendly, PDF & Email
Details

Mușat & Asociații advised Naxxar Renewable Energy on the sale of the remaining 40% stake in Naxxar Wind Farm Four to the Polish group Polenergia

Press News 2024

Bucharest, 3 October 2024 Mușat & Asociații advised Naxxar Renewable Energy on the sale of the remaining 40% stake in Naxxar Wind Farm Four SRL (NX4 – the project company) to Polenergia, the largest private energy group on the Polish market. Polenergia has thus exercised its option to buy the remaining shares in NX4, provided…

Print Friendly, PDF & Email
Details

The identity of an economic entity within a business transfer in the light of Directive 2001/23 and CJEU practice

News News 2024

Authors: Mihai Popa, Deputy Managing Partner, Mușat & Asociații Simona Anton, Managing Associate, Mușat & Asociații   The business transfer inevitably impacts on employment relationships, a context in which the identity of the economic entity has been the subject of exhaustive analysis in recent case-law of the Court of Justice of the European Union (CJEU).…

Print Friendly, PDF & Email
Details

Mușat & Asociații team won an important dispute against CNAS for a client in the pharmaceutical industry regarding the application of the legislation on the calculation of the clawback tax

News Press News 2024

Press release Bucharest, 5 June 2024   Mușat & Asociații represented a multinational pharmaceutical company in a complex dispute with the National Health Insurance House (CNAS) regarding the clawback tax for medicines, in the context of the concurrent application of two special regulations with contradictory provisions, namely GEO No. 31/2020 and Law No. 53/2020. The…

Print Friendly, PDF & Email
Details